Literature DB >> 17277951

Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration.

Timothy E Bunchman1, Gina-Marie Barletta, John W Winters, John J Gardner, Teri L Crumb, Kevin D McBryde.   

Abstract

An infant with a suspected inborn metabolism error was treated with a metabolic cocktail of intravenous sodium phenylacetate (NaPh) and sodium benzoate (NaBz) for hyperammonemia. Sequential hemodialysis (HD) then hemofiltration (HF) was performed due to hyperammonemia. Dialytic and convective clearance (K; ml/min) of ammonia, NaPh, and NaBz was measured. The K of ammonia was 57 and 37 for HD and HF, respectively. The K of NaBz was 37 and 12 for HD and HF, respectively. The K of NaPh was 38 and 14 ml/min for HD and HF, respectively. Despite high clearance of both NaPh and NaBz by HD and HF, the hyperammonemia was corrected.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17277951     DOI: 10.1007/s00467-007-0436-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators.

Authors:  S Picca; C Dionisi-Vici; D Abeni; A Pastore; C Rizzo; M Orzalesi; G Sabetta; G Rizzoni; A Bartuli
Journal:  Pediatr Nephrol       Date:  2001-11       Impact factor: 3.714

2.  AN-69 membrane reactions are pH-dependent and preventable.

Authors:  P D Brophy; T A Mottes; T L Kudelka; K D McBryde; J J Gardner; N J Maxvold; T E Bunchman
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

3.  Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation.

Authors:  Timothy E Bunchman; Norma J Maxvold; Joni Barnett; Anne Hutchings; Mark R Benfield
Journal:  Pediatr Nephrol       Date:  2002-03       Impact factor: 3.714

4.  Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency.

Authors:  Kevin D McBryde; Timothy L Kudelka; David B Kershaw; Patrick D Brophy; John J Gardner; William E Smoyer
Journal:  J Pediatr       Date:  2004-04       Impact factor: 4.406

5.  Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism.

Authors:  Kevin D McBryde; David B Kershaw; Timothy E Bunchman; Norma J Maxvold; Theresa A Mottes; Timothy L Kudelka; Patrick D Brophy
Journal:  J Pediatr       Date:  2006-06       Impact factor: 4.406

6.  Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.

Authors:  Timothy E Bunchman; Norma J Maxvold; Patrick D Brophy
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

7.  Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

Authors:  M Msall; M L Batshaw; R Suss; S W Brusilow; E D Mellits
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

8.  Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers.

Authors:  Robert B MacArthur; Arman Altincatal; Mendel Tuchman
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

  8 in total
  9 in total

1.  A biphasic dialytic strategy for the treatment of neonatal hyperammonemia.

Authors:  Mark Hanudel; Sonal Avasare; Eileen Tsai; Ora Yadin; Joshua Zaritsky
Journal:  Pediatr Nephrol       Date:  2014-02       Impact factor: 3.714

2.  The complexity of dialytic therapy in hyperammonemic neonates.

Authors:  Timothy E Bunchman
Journal:  Pediatr Nephrol       Date:  2015-03-07       Impact factor: 3.714

3.  Short-term survival of hyperammonemic neonates treated with dialysis.

Authors:  Stefano Picca; Carlo Dionisi-Vici; Andrea Bartuli; Tommaso De Palo; Francesco Papadia; Giovanni Montini; Marco Materassi; Maria Alice Donati; Enrico Verrina; Maria Cristina Schiaffino; Carmine Pecoraro; Emilia Iaccarino; Enrico Vidal; Alberto Burlina; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2014-09-04       Impact factor: 3.714

4.  Sodium benzoate for treatment of hepatic encephalopathy.

Authors:  Michael L Misel; Robert G Gish; Heather Patton; Michel Mendler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-04

5.  Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience.

Authors:  Claire Westrope; Kevin Morris; David Burford; Gavin Morrison
Journal:  Pediatr Nephrol       Date:  2010-05-22       Impact factor: 3.714

Review 6.  Hyperammonemia in review: pathophysiology, diagnosis, and treatment.

Authors:  Ari Auron; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-03-23       Impact factor: 3.714

Review 7.  The Role of RRT in Hyperammonemic Patients.

Authors:  Shruti Gupta; Andrew Z Fenves; Robert Hootkins
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-19       Impact factor: 8.237

8.  High-dose continuous renal replacement therapy for neonatal hyperammonemia.

Authors:  Joann M Spinale; Benjamin L Laskin; Neal Sondheimer; Sarah J Swartz; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2013-03-08       Impact factor: 3.714

Review 9.  Management of toxic ingestions with the use of renal replacement therapy.

Authors:  Timothy E Bunchman; Maria E Ferris
Journal:  Pediatr Nephrol       Date:  2010-10-12       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.